Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shrikant Anant

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Trends in Cardiovascular Medicine|November 30, 2002
Identification and regulation of protein components of the apolipoprotein B mRNA editing enzyme. A complex eventShrikant Anant, Nicholas O Davidson
Trends in Molecular Medicine|May 3, 2003
Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer?Shrikant Anant, Nicholas O Davidson
Gastroenterology|March 31, 2009
HuR and TTP: two RNA binding proteins that deliver message from the 3' endShrikant Anant, Courtney W Houchen
Current Pharmacology Reports|June 2, 2015
Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapySatish Ramalingam, Dharmalingam Subramaniam, Shrikant Anant
Frontiers in Endocrinology|January 30, 2023
Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategiesDavid Standing, Prasad Dandawate, Shrikant Anant
Progress in Nucleic Acid Research and Molecular Biology|November 8, 2003
Molecular regulation, evolutionary, and functional adaptations associated with C to U editing of mammalian apolipoproteinB mRNAShrikant Anant, Valerie Blanc, Nicholas O Davidson
Molecular Carcinogenesis|October 28, 2016
Stromal contributions to the carcinogenic processMark Spaw, Shrikant Anant, Sufi Mary Thomas
Current Opinion in Gastroenterology|February 8, 2006
Molecular biology of the small intestineVineet Ahuja, Brian K Dieckgraefe, Shrikant Anant
Immuno-Gastroenterology|June 25, 2013
Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon CancerSatish Ramalingam, Prabhu Ramamoorthy, Dharmalingam Subramaniam, et al.
Current Medicinal Chemistry|February 1, 2017
Targeting Cancer Stem Cells for Chemoprevention of Pancreatic CancerDharmalingam Subramaniam, Gaurav Kaushik, Prasad Dandawate, et al.
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Trends in Cardiovascular Medicine|November 30, 2002
Identification and regulation of protein components of the apolipoprotein B mRNA editing enzyme. A complex eventShrikant Anant, Nicholas O Davidson
Trends in Molecular Medicine|May 3, 2003
Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer?Shrikant Anant, Nicholas O Davidson
Gastroenterology|March 31, 2009
HuR and TTP: two RNA binding proteins that deliver message from the 3' endShrikant Anant, Courtney W Houchen
Current Pharmacology Reports|June 2, 2015
Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapySatish Ramalingam, Dharmalingam Subramaniam, Shrikant Anant
Frontiers in Endocrinology|January 30, 2023
Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategiesDavid Standing, Prasad Dandawate, Shrikant Anant
Progress in Nucleic Acid Research and Molecular Biology|November 8, 2003
Molecular regulation, evolutionary, and functional adaptations associated with C to U editing of mammalian apolipoproteinB mRNAShrikant Anant, Valerie Blanc, Nicholas O Davidson
Molecular Carcinogenesis|October 28, 2016
Stromal contributions to the carcinogenic processMark Spaw, Shrikant Anant, Sufi Mary Thomas
Current Opinion in Gastroenterology|February 8, 2006
Molecular biology of the small intestineVineet Ahuja, Brian K Dieckgraefe, Shrikant Anant
Immuno-Gastroenterology|June 25, 2013
Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon CancerSatish Ramalingam, Prabhu Ramamoorthy, Dharmalingam Subramaniam, et al.
Current Medicinal Chemistry|February 1, 2017
Targeting Cancer Stem Cells for Chemoprevention of Pancreatic CancerDharmalingam Subramaniam, Gaurav Kaushik, Prasad Dandawate, et al.
Pageof 16